Road to Future: iPSC Clinical Application in Parkinson’s Disease Treatment

Author(s): L. Xu, Y. -Y. Tan, L. Wu, L -L. Wang, H. Li, J.-Q. Ding, S.-D. Chen

Journal Name: Current Molecular Medicine

Volume 13 , Issue 9 , 2013

Become EABM
Become Reviewer
Call for Editor


Cell-replacement therapy using Parkinson’s disease (PD) specific induced pluripotent stem cell (iPSC) holds great promise in treating PD. However, the problem of iPSC safety and efficiency restrict its clinical application. Meanwhile the requirement of skin biopsy for fibroblast will increase the risk of complication. In the past few years, the advances of iPSC technology in efficiency, cell resource, safety and cell culture have made it possible to use the derivatives of iPSCs to clinical PD treatment. This review will summarize these progresses of iPSC technique in this fast-moving community.

Keywords: iPSC, Parkinson's disease, reprogramming, treatment.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 21 August, 2013
Page: [1412 - 1418]
Pages: 7
DOI: 10.2174/15665240113139990070
Price: $65

Article Metrics

PDF: 26